Clobetasol Cream

País: Nova Zelândia

Língua: inglês

Origem: Medsafe (Medicines Safety Authority)

Ingredientes ativos:

Clobetasol propionate 0.5 mg/g

Disponível em:

Boucher & Muir (New Zealand) Limited t/a BNM Group

DCI (Denominação Comum Internacional):

Clobetasol propionate 0.5 mg/g

Dosagem:

0.5 mg/g

Forma farmacêutica:

Topical cream

Composição:

Active: Clobetasol propionate 0.5 mg/g Excipient: Cetostearyl alcohol Chlorocresol Citric acid monohydrate Glycerol Glyceryl 1-monostearate Propylene glycol Purified water Sodium citrate White beeswax

Tipo de prescrição:

Prescription

Fabricado por:

Symbiotec Pharmalab Limited

Indicações terapêuticas:

Treatment of resistant dermatoses such as psoriasis (excluding widespread plaque psoriasis), recalcitrant eczemas, lichen planus and discoid lupus eyrthematosus and other skin conditions which do not respond satisfactorily to less active steroids.

Resumo do produto:

Package - Contents - Shelf Life: Tube, aluminium, laquered, collapsible aluminium tube with polypropylene cap, secondary carton - 30 g - 24 months from date of manufacture stored at or below 25°C 3 months opened stored at or below 30°C. (in use) - Tube, aluminium, laquered, collapsible aluminium tube with polypropylene cap, secondary carton - 100 g - 24 months from date of manufacture stored at or below 25°C 3 months opened stored at or below 30°C. (in use)

Data de autorização:

2014-05-05

Folheto informativo - Bula

1
CLOBETASOL CREAM
CLOBETASOL OINTMENT
15092016
New Zealand Consumer Medicine Information
CLOBETASOL CREAM
CLOBETASOL OINTMENT
_ _
_CLOBETASOL PROPIONATE _0.05% W/W
_ _
CREAM / OINTMENT
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully before you start using Clobetasol
Cream or Ointment.
This leaflet answers some common questions about Clobetasol Cream and
Ointment. It
does not contain all the available information. The most up-to-date
Consumer Medicine
Information can be downloaded from www.medsafe.govt.nz.
Reading this leaflet does not take the place of talking to your doctor
or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you using
Clobetasol Cream or Ointment against the benefits this medicine is
expected to have for
you.
IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may want to read it again.
WHAT CLOBETASOL CREAM AND OINTMENT ARE USED FOR
Clobetasol Cream and Ointment contain the active ingredient clobetasol
propionate.
Clobestasol belongs to a group of medicines known as topical steroids.
“Topical” means
that they are applied onto the skin. Topical steroids are used to help
reduce inflammation
in the affected area which helps to reduce redness and itchiness
caused by the skin
disease.
Clobetasol Cream and Ointment are used to treat various inflamed skin
conditions which
do not respond to less active steroids, including:

psoriasis (a stubborn skin disorder with raised, rough, reddened areas
covered with
dry, fine silvery scales)

severe forms of eczema (an often itchy skin condition with redness,
swelling, oozing
of fluid, crusting which may lead to scaling)

lichen planus (chronic itchy skin of unknown origin)

discoid lupus erythematosus (recurring scaly rash)
2
CLOBETASOL CREAM
CLOBETASOL OINTMENT
15092016
Clobetasol Cream is used to treat skin conditions on moist or weeping
surfaces whereas
Clobetasol Ointment is more suitable for dry, scaly skin.
Your doctor

Características técnicas

1
CLOBETASOL CREAM
CLOBETASOL OINTMENT
26082016
NEW ZEALAND DATA SHEET
CLOBETASOL CREAM
CLOBETASOL OINTMENT
clobetasol propionate
CREAM AND OINTMENT
0.05% w/w
PRESENTATIONS
Clobetasol Cream and Ointment each contain 0.05% w/w clobetasol
propionate (1 g of
cream/ointment contains 0.5 mg of clobetasol 17-propionate).
The water-miscible cream and the paraffin-based ointment are both
white in appearance.
INDICATIONS
Treatment
of
resistant
dermatoses
such
as
psoriasis
(excluding
widespread
plaque
psoriasis), recalcitrant eczemas, lichen planus and discoid lupus
erythematosus and other
skin conditions which do not respond satisfactorily to less active
steroids.
DOSAGE AND ADMINISTRATION
Creams are especially appropriate for moist or weeping surfaces.
Ointments are especially
appropriate for dry, lichenified or scaly lesions.
Adults, elderly and children over 1 year
_ _
Apply thinly and gently rub in using only enough to cover the entire
affected area once or
twice daily until improvement occurs (in the more responsive
conditions this may be within
a few days), then reduce the frequency of application or change the
treatment to a less
potent preparation. Allow adequate time for absorption after each
application before
applying an emollient.
Repeated
short courses
of
Clobetasol
Cream
or Ointment may
be used to control
exacerbations.
In very resistant lesions, especially where there is hyperkeratosis,
the effect of Clobetasol
Cream or Ointment can be enhanced, if necessary, by occluding the
treatment area with
polythene film. Overnight occlusion only is usually adequate to bring
about a satisfactory
response. Thereafter improvement can usually be maintained by
application without
occlusion.
2
CLOBETASOL CREAM
CLOBETASOL OINTMENT
26082016
If the condition worsens or does not improve within 2-4 weeks,
treatment and diagnosis
should be re-evaluated.
Treatment should not be continued for more than 4 weeks. If continuous
treatment is
necessary, a less potent preparation should be used.
The maximum weekly dose should not exceed